Evotec SE
FSX:EVT.DE
6.46 (EUR) • At close September 18, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Evotec SE |
Symbool | EVT.DE |
Munteenheid | EUR |
Prijs | 6.46 |
Beurswaarde | 1,145,377,929 |
Dividendpercentage | 0% |
52-weken bereik | 5.06 - 21.84 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Werner Lanthaler M.B.A., MBA, MPA, Ph.D. |
Website | https://www.evotec.com |
An error occurred while fetching data.
Over Evotec SE
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)